Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding.
暂无分享,去创建一个
Carolin Mügge | Wolfgang Weigand | G. Ferraro | A. Merlino | W. Weigand | L. Massai | L. Messori | N. Metzler‐Nolte | Carolin Mügge | Nils Metzler-Nolte | Pablo Rivera-Fuentes | Luigi Messori | Antonello Merlino | Tiziano Marzo | Lara Massai | Giarita Ferraro | Jana Hildebrandt | J. Hildebrandt | T. Marzo | Pablo Rivera‐Fuentes
[1] A. Merlino,et al. The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme. , 2014, Chemical communications.
[2] N. Metzler‐Nolte,et al. Biologically Active Trifluoromethyl-Substituted Metallocene Triazoles: Characterization, Electrochemistry, Lipophilicity, and Cytotoxicity , 2012 .
[3] James L. Hickey,et al. Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity. , 2006, Dalton transactions.
[4] Domenico Osella,et al. The RP-HPLC measurement and QSPR analysis of logP(o/w) values of several Pt(II) complexes. , 2006, Journal of inorganic biochemistry.
[5] Dong Wang,et al. Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.
[6] A. Merlino,et al. Interactions of gold-based drugs with proteins: the structure and stability of the adduct formed in the reaction between lysozyme and the cytotoxic gold(III) compound Auoxo3. , 2014, Dalton transactions.
[7] P. Tchounwou,et al. Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.
[8] K. Diederichs,et al. Carboplatin binding to histidine , 2014, Acta crystallographica. Section F, Structural biology communications.
[9] N. Pannu,et al. REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.
[10] M. Dolan,et al. Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.
[11] A. Vergara,et al. Investigating the ruthenium metalation of proteins: X-ray structure and Raman microspectroscopy of the complex between RNase A and AziRu. , 2013, Inorganic chemistry.
[12] H. Görls,et al. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions. , 2014, Dalton transactions.
[13] Randy J. Read,et al. Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.
[14] G. Natile,et al. Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA , 2009 .
[15] Reactions of cytotoxic metallodrugs with lysozyme in pure DMSO explored through UV–Vis absorption spectroscopy and ESI MS , 2015, BioMetals.
[16] G. Natile,et al. An Updated View of Cisplatin Transport , 2013 .
[17] B. Spingler,et al. Tricarbonylmanganese(I) and –rhenium(I) Complexes of Imidazol‐Based Phosphane Ligands: Influence of the Substitution Pattern on the CO Release Properties , 2009 .
[18] A. Merlino,et al. Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme. , 2013, Inorganic chemistry.
[19] Jan Reedijk,et al. Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry? , 2012 .
[20] Michael Groessl,et al. Anticancer metallodrug research analytically painting the “omics” picture—current developments and future trends , 2013, Analytical and Bioanalytical Chemistry.
[21] W. Berger,et al. In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS. , 2013, Metallomics : integrated biometal science.
[22] Rita Grandori,et al. Testing the role of solvent surface tension in protein ionization by electrospray. , 2005, Journal of mass spectrometry : JMS.
[23] C. Supuran,et al. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme. , 2007, Chemical communications.
[24] T. Hambley,et al. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs , 2000, British Journal of Cancer.
[25] A. Merlino,et al. Oxaliplatin vs. cisplatin: competition experiments on their binding to lysozyme. , 2015, Dalton transactions.
[26] R. Silaghi-Dumitrescu,et al. Interactions between proteins and platinum-containing anti-cancer drugs. , 2011, Mini reviews in medicinal chemistry.
[27] A. Merlino,et al. Interactions between anticancer trans-platinum compounds and proteins: crystal structures and ESI-MS spectra of two protein adducts of trans-(dimethylamino)(methylamino)dichloridoplatinum(II). , 2014, Inorganic chemistry.
[28] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[29] A. Berthod,et al. Determination of liquid-liquid partition coefficients by separation methods. , 2004, Journal of chromatography. A.
[30] H. Görls,et al. Synthese und Charakterisierung funktionalisierter β‐Hydroxydithiozimtsäuren und deren Ester. Komplexchemisches Verhalten gegenüber Nickel(II), Palladium(II) und Platin(II) , 2006 .
[31] D. F. Koenig,et al. Structure of Hen Egg-White Lysozyme: A Three-dimensional Fourier Synthesis at 2 Å Resolution , 1965, Nature.
[32] A. Merlino,et al. Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c.). , 2014, ACS medicinal chemistry letters.
[33] A. Merlino,et al. Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme. , 2014, Dalton transactions.
[34] J. Helliwell,et al. The crystal structure analysis of the relative binding of cisplatin and carboplatin in a mixture with histidine in a protein studied at 100 and 300 K with repeated X-ray irradiation. , 2013, Acta crystallographica. Section D, Biological crystallography.
[35] L. Kèlland,et al. The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.
[36] M. A. Patrick,et al. A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography. , 1988, Journal of medicinal chemistry.
[37] N. Farrell,et al. Platinum-based drugs and proteins: reactivity and relevance to DNA adduct formation. , 2013, Journal of inorganic biochemistry.
[38] M. Palacios,et al. Analytical methodologies for metallomics studies of antitumor Pt-containing drugs. , 2010, Metallomics : integrated biometal science.
[39] J. Helliwell,et al. Structural studies of the effect that dimethyl sulfoxide (DMSO) has on cisplatin and carboplatin binding to histidine in a protein. , 2012, Acta crystallographica. Section D, Biological crystallography.
[40] A. Vergara,et al. The mode of action of anticancer gold-based drugs: a structural perspective. , 2013, Chemical communications.